Brii Biosciences stops manufacturing Covid-19 antibody combo, plans to withdraw EUA request

Kyle LaHucik

Senior Reporter

Brii Biosciences said it will stop manufacturing its Covid-19 antibody combination, sold in China, and is working to withdraw its emergency use authorization request in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Brii Biosciences stops manufacturing Covid-19 antibody combo, plans to withdraw EUA request

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

Netherlands pours $1.5B into biotech in pursuit of global leadership ambitions

Exclusive: BigHat inks Lilly deal for AI-boosted antibodies, extends Series B

Pharma's wins and losses in Trump's sprawling executive order on drug prices

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Brii Bio­sciences stops man­u­fac­tur­ing Covid-19 an­ti­body com­bo, plans to with­draw EUA re­quest

Senior Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Brii Biosciences stops manufacturing Covid-19 antibody combo, plans to withdraw EUA request